Structure Analysis of Wild type HIV-I Proteases

International Journal of Biotech Trends and Technology (IJBTT)
© 2016 by IJBTT Journal
Volume - 6 Issue - 2                          
Year of Publication : 2016
Authors : R. SreeLatha, K. Ramya


R. SreeLatha, K. Ramya "Structure Analysis of Wild type HIV-I Proteases", International Journal of Biotech Trends and Technology (IJBTT), V6(2): 23-25 Apr - Jun 2016. Published by Seventh Sense Research Group.


Understanding the reactivity of the human immunodeficiency virus (HIV–1)is an emerging area in the field of drug design. The present article high lights the structure analysis of HIV-1 protease.


1. Wlodawer, A., Miller, M., Jaskolski, M., Sathyanarayana, B.K., Baldwin, E., Weber, I.T., Selk, L.M., Clawson, L., Schneider, J., Kent., S.B.H. Science 1989, 245, 616-621.
2. Kramer, R. A.; Schaber, M. D.; Skalka, A. M.; Ganguly, K.; Wong-Staal, F.; Reddy, E. P. HTLV-III gag Protein Is Processed in Yeast Cells by the Virus pol-Protease. Science 1986, 231, 1580-1585`.
3. R. SreeLatha, R. Vijayaraj, E. R. AzhagiyaSingam, K. Chitra and V. Subramanian, “3D-QSAR and Docking Studies on the HEPT Derivatives of HIV-1 Reverse Transcriptase”, Chemical Biology & Drug Design 78 (2011) 418–426. (Camila S, et al., 2004)
4. PDB code Crystal structures of complexes of a peptidic inhibitor with wild-type and two mutant HIV-1 proteases Biochemistry1996.
5. Alexander Wlodawer and Jiri Vondrasek (1998).INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug Design. Annu. Rev. Biophys.Biomol. Struct. 27:249-84
6. P. J. Gane and P. M. Dean, “Recent advances in structurebased rational drug design”, Current Opinion in. Structural Biology, 2000, 10, 401-404. (Marrone TJ, Briggs JM and McCammon ,1997)
7. J. A. EWING, IRWIN D. KUNTZ ... Sons, Inc. J ComputChem 18: 11751189, 1997
8. Wang J, Kollman PA and Kuntz ID Understanding the bacterial polysaccharide antigenicity of Streptococcus 104:203–209,1999
9. Carlson H.A., McCammon J.A. (2000) Accommodating Protein Flexibility inComputational Drug Design. Molecular Pharmacology 57: 213-218
10. Toraskar, Mrunmayee P.. "HIV-1 Protease Inhibitor : A Review", Journal of Pharmacy Research/09746943, 2009 Publication
11. Balakrishnan, M.. "Homology Modeling andDocking Studies Between HIV-1 Protease andBeta Mercapto Ethanol", IUP Journal ofBiotechnology/0973849520091201
12. Udayakumar, R., Kaliyamurthie, K.P., Khanaa, Thooyamani, K.P., Data mining a boon: Predictive system for university topper women in academia, World Applied Sciences Journal, v-29, i-14, pp-86-90, 2014.
13. Lingeswaran, K., Prasad Karamcheti, S.S., Gopikrishnan, M., Ramu, G., Preparation and characterization of chemical bath deposited cds thin film for solar cell, Middle - East Journal of Scientific Research, v-20, i-7, pp-812-814, 2014.
14. Premkumar, S., Ramu, G., Gunasekaran, S., Baskar, D., Solar industrial process heating associated with thermal energy storage for feed water heating, Middle - East Journal of Scientific Research, v-20, i-11, pp-1686-1688, 2014.
15. Gopalakrishnan, K., Sundeep Aanand, J., Udayakumar, R., Electrical properties of doped azopolyester, Middle - East Journal of Scientific Research, v-20, i-11, pp-1402-1412, 2014.
16. Achudhan, M., Prem Jayakumar, M., Mathematical modeling and control of an electrically-heated catalyst, International Journal of Applied Engineering Research, v-9, i-23, pp- 23013-, 2014.
17. Thooyamani, K.P., Khanaa, V., Udayakumar, R., Application of pattern recognition for farsi license plate recognition, Middle - East Journal of Scientific Research, v-18, i-12, pp- 1768-1774, 2013.

HIV–1, aspartylprotease.